Current Environment:

Age
Can use: Conditions, Treatments, Doctor's Name, or NCT Id.
Trial Phases
Gender

Clinical Trials

MIBG With Dinutuximab +/- Vorinostat

131I-Metaiodobenzylguanidine (131I-MIBG) is one of the most effective therapies utilized for neuroblastoma patients with refractory or relapsed disease. In this pediatric phase 1 trial, 131I-MIBG will...

Read More

The PediQUEST Response Intervention Study

PediQUEST Response proposes a new system of care that expects to improve quality of life in children, adolescents, and young adults with advanced cancer and their parents. The investigators want to...

Read More

DAY101 In Gliomas and Other Tumors

This research study is studying a drug Tovorafenib/DAY101 (formerly TAK-580, MLN2480) as a possible treatment a low-grade glioma that has not responded to other treatments. The name of the study drug...

Read More